Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
82,051,282
-
Total 13F shares
-
91,362,527
-
Share change
-
+757,904
-
Total reported value
-
$1,231,596,559
-
Put/Call ratio
-
60%
-
Price per share
-
$13.48
-
Number of holders
-
174
-
Value change
-
-$2,448,888
-
Number of buys
-
90
-
Number of sells
-
80
Institutional Holders of Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value (VRDN) as of Q1 2025
As of 31 Mar 2025,
Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value (VRDN) was held by
174 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
91,362,527 shares.
The largest 10 holders included
FMR LLC, BlackRock, Inc., Deep Track Capital, LP, Kynam Capital Management, LP, VANGUARD GROUP INC, VR ADVISER, LLC, COMMODORE CAPITAL LP, Fairmount Funds Management LLC, STATE STREET CORP, and TANG CAPITAL MANAGEMENT LLC.
This page lists
174
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.